Get started
Author

Roy F.P.M. Kruitwagen

Observed names: Kruitwagen R.F.P.M., Kruitwagen RF, Kruitwagen Roy, Kruitwagen, R, Kruitwagen, R., Kruitwagen, R. F., Kruitwagen, R.F., Kruitwagen, R.F.P.M, Kruitwagen, R.F.P.M., Kruitwagen, R.FP.M., Kruitwagen, Roy, Kruitwagen, Roy F. P. M., Kruitwagen, Roy FPM, Kruitwagen, Rutgerus Franciscus Petrus Maria, R F Kruitwagen, R F P M Kruitwagen, R F. M. P. Kruitwagen, R. F. P. M. KRUITWAGEN, R. F. P. M. Kruitwagen, R. F.M. Kruitwagen, R. Kruitwagen, R. Kruitwagen Tilburg, R.F. Kruitwagen, R.F.M.P. KRUITWAGEN, R.F.M.P. Kruitwagen, R.F.P.M Kruitwagen, R.F.P.M. Kruitwagen, R.F.PM. Kruitwagen, R.P.F.M. Kruitwagen, R.o.y. Kruitwagen, RF Kruitwagen, RFPM Kruitwagen, Roy F Kruitwagen, Roy F P M Kruitwagen, Roy F. Kruitwagen, Roy F. L. P. Kruitwagen, Roy F. M. P. Kruitwagen, Roy F. P. M. Kruitwagen, Roy F.P.M Kruitwagen, Roy F.PM. Kruitwagen, Roy FKruitwagen, Roy FPM Kruitwagen, Roy FPM. Kruitwagen, Roy Kruitwagen, Roy P.M. Kruitwagen, Roy.F.P.M. Kruitwagen, Rutgerus F. P. M. Kruitwagen, Rutgerus F.P.M. Kruitwagen, Rutgerus FPM Kruitwagen, Rutgerus Franciscus, Rutgerus Franciscus Petrus Maria Kruitwagen, Rutgerus Kruitwagen
Observed institutions: Radboud University Nijmegen, Tilburg University, Justus-Liebig-Universität Gießen, Leiden University Medical Center, Maastricht University Medical Centre, Gelre Hospitals, Ghent University Hospital, Catharina Ziekenhuis, Erasmus MC, Amsterdam UMC Location University of Amsterdam, Radboud University Medical Center, The Netherlands Cancer Institute, University Medical Center Utrecht, Maastricht University, Albert Schweitzer Ziekenhuis, VIB-KU Leuven Center for Cancer Biology, Slingeland Ziekenhuis, Amphia Ziekenhuis, Cancer Research Institute Ghent, Máxima Medisch Centrum, Atrium Medisch Centrum Parkstad, Bronovo Hospital, Elisabeth-TweeSteden Ziekenhuis, Rijnstate Hospital, Eindhoven Cancer Registry, Jeroen Bosch Ziekenhuis, Maastro Clinic, Maaslandziekenhuis, University of Birmingham, Amsterdam UMC Location Vrije Universiteit Amsterdam, Erasmus University Rotterdam, KU Leuven
ORCID: 0000-0002-1305-9541
Observed ORCIDs: 0000-0002-1305-9541, 0000-0002-2409-6735
OpenAlex ID: A5006180747
Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysis
2013 · R. P. G. ten Broek, Y. Issa, et al. · BMJ · 687
PDF
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
2018 · Stephanie M de Boer, Melanie E Powell, et al. · The Lancet Oncology · 642
PDF
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
2019 · Stephanie M de Boer, Melanie E Powell, et al. · The Lancet Oncology · 457
PDF
Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis
2016 · E.M.J. Meys, J. Kaijser, et al. · European Journal of Cancer · 271
Does three‐dimensional anatomy improve student understanding?
2019 · Charlotte P. R. Triepels, Carlijn F. A. Smeets, et al. · Clinical Anatomy · 208
PDF
Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
2016 · Iris J.G. Rutten, David P.J. van Dijk, et al. · Journal of Cachexia Sarcopenia and Muscle · 207
PDF
Lymph node metastasis in stages I and II ovarian cancer: A review
2011 · M. Kleppe, T. Wang, et al. · Gynecologic Oncology · 205
Endometrial epithelial cells in peritoneal fluid during the early follicular phase
1991 · Roy F.P.M. Kruitwagen, Lambert G. Poels, et al. · Fertility and Sterility · 203
Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer
2017 · Iris J.G. Rutten, Jorne Ubachs, et al. · Journal of Cachexia Sarcopenia and Muscle · 185
PDF
The Accuracy of Risk Scores in Predicting Ovarian Malignancy
2009 · Peggy Geomini, Roy Kruitwagen, et al. · Obstetrics and Gynecology · 185
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
2016 · Stephanie M de Boer, Melanie E Powell, et al. · The Lancet Oncology · 178
PDF
Sarcopenia and ovarian cancer survival: a systematic review and meta‐analysis
2019 · Jorne Ubachs, Janine Ziemons, et al. · Journal of Cachexia Sarcopenia and Muscle · 173
PDF
Dutch Translation and Psychometric Testing of the 9-Item Shared Decision Making Questionnaire (SDM-Q-9) and Shared Decision Making Questionnaire-Physician Version (SDM-Q-Doc) in Primary and Secondary Care
2015 · Sumayah Rodenburg-Vandenbussche, Arwen H. Pieterse, et al. · PLoS ONE · 169
PDF
Health-Related Quality of Life in Cervical Cancer Survivors: A Population-Based Survey
2008 · Ida J. Korfage, Marie-Louise Essink-Bot, et al. · International Journal of Radiation Oncology*Biology*Physics · 163
Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients
2021 · Jorne Ubachs, Janine Ziemons, et al. · Journal of Cachexia Sarcopenia and Muscle · 161
No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands
2017 · M. Timmermans, G.S. Sonke, et al. · European Journal of Cancer · 148
PDF
The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study
2005 · H.A.A.M. Maas, R.F.P.M. Kruitwagen, et al. · Gynecologic Oncology · 137
Incidence and Effect on Survival of Abdominal Wall Metastases at Trocar or Puncture Sites Following Laparoscopy or Paracentesis in Women with Ovarian Cancer
1996 · R.F.P.M. Kruitwagen, B.M. Swinkels, et al. · Gynecologic Oncology · 136
Ovarian stimulation and granulosa-cell tumour
1993 · W.N.P. Willemsen, R.F.P.M. Kruitwagen, et al. · The Lancet · 134
The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery
2017 · I.J.G. Rutten, J. Ubachs, et al. · European Journal of Surgical Oncology · 115
PDF
Impact of an Automatically Generated Cancer Survivorship Care Plan on Patient-Reported Outcomes in Routine Clinical Practice: Longitudinal Outcomes of a Pragmatic, Cluster Randomized Trial
2015 · Kim A.H. Nicolaije, Nicole P.M. Ezendam, et al. · Journal of Clinical Oncology · 112
Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods
2016 · E. M. J. Meys, L. S. Jeelof, et al. · Ultrasound in Obstetrics and Gynecology · 110
PDF
High Concordance of Results of Testing for Human Papillomavirus in Cervicovaginal Samples Collected by Two Methods, with Comparison of a Novel Self-Sampling Device to a Conventional Endocervical Brush
2006 · Antoinette A. T. P. Brink, Chris J. L. M. Meijer, et al. · Journal of Clinical Microbiology · 105
Diagnostic accuracy of frozen section diagnosis of the adnexal mass: a metaanalysis
2004 · Peggy Geomini, Gérard Bremer, et al. · Gynecologic Oncology · 105
Understanding Lymphatic Drainage Pathways of the Ovaries to Predict Sites for Sentinel Nodes in Ovarian Cancer
2015 · Marjolein Kleppe, Anne C. Kraima, et al. · International Journal of Gynecological Cancer · 90
PDF
Works count: 342
Citation count: 9,443
H-index: 47
I10-index: 157
Year
Topic
Type